221 related articles for article (PubMed ID: 31501143)
1. PD-1 Blockade and TLR7 Activation Lack Therapeutic Benefit in Chronic Simian Immunodeficiency Virus-Infected Macaques on Antiretroviral Therapy.
Bekerman E; Hesselgesser J; Carr B; Nagel M; Hung M; Wang A; Stapleton L; von Gegerfelt A; Elyard HA; Lifson JD; Geleziunas R
Antimicrob Agents Chemother; 2019 Nov; 63(11):. PubMed ID: 31501143
[TBL] [Abstract][Full Text] [Related]
2. Exacerbated AIDS Progression by PD-1 Blockade during Therapeutic Vaccination in Chronically Simian Immunodeficiency Virus-Infected Rhesus Macaques after Interruption of Antiretroviral Therapy.
Wu C; He Y; Zhao J; Luo K; Wen Z; Zhang Y; Li M; Cui Y; Liu Z; Wang C; Han Z; Li G; Feng F; Li P; Chen L; Sun C
J Virol; 2022 Feb; 96(3):e0178521. PubMed ID: 34818070
[TBL] [Abstract][Full Text] [Related]
3. CTLA-4 and PD-1 dual blockade induces SIV reactivation without control of rebound after antiretroviral therapy interruption.
Harper J; Gordon S; Chan CN; Wang H; Lindemuth E; Galardi C; Falcinelli SD; Raines SLM; Read JL; Nguyen K; McGary CS; Nekorchuk M; Busman-Sahay K; Schawalder J; King C; Pino M; Micci L; Cervasi B; Jean S; Sanderson A; Johns B; Koblansky AA; Amrine-Madsen H; Lifson J; Margolis DM; Silvestri G; Bar KJ; Favre D; Estes JD; Paiardini M
Nat Med; 2020 Apr; 26(4):519-528. PubMed ID: 32284611
[TBL] [Abstract][Full Text] [Related]
4. Bone Marrow-Derived CD4
Hoang TN; Harper JL; Pino M; Wang H; Micci L; King CT; McGary CS; McBrien JB; Cervasi B; Silvestri G; Paiardini M
J Virol; 2019 Jan; 93(1):. PubMed ID: 30305357
[TBL] [Abstract][Full Text] [Related]
5. Brain Macrophages in Simian Immunodeficiency Virus-Infected, Antiretroviral-Suppressed Macaques: a Functional Latent Reservoir.
Avalos CR; Abreu CM; Queen SE; Li M; Price S; Shirk EN; Engle EL; Forsyth E; Bullock BT; Mac Gabhann F; Wietgrefe SW; Haase AT; Zink MC; Mankowski JL; Clements JE; Gama L
mBio; 2017 Aug; 8(4):. PubMed ID: 28811349
[TBL] [Abstract][Full Text] [Related]
6. Short-Term Pegylated Interferon α2a Treatment Does Not Significantly Reduce the Viral Reservoir of Simian Immunodeficiency Virus-Infected, Antiretroviral Therapy-Treated Rhesus Macaques.
Palesch D; Bosinger SE; Mavigner M; Billingsley JM; Mattingly C; Carnathan DG; Paiardini M; Chahroudi A; Vanderford TH; Silvestri G
J Virol; 2018 Jul; 92(14):. PubMed ID: 29720521
[TBL] [Abstract][Full Text] [Related]
7. Combination anti-PD-1 and antiretroviral therapy provides therapeutic benefit against SIV.
Mylvaganam GH; Chea LS; Tharp GK; Hicks S; Velu V; Iyer SS; Deleage C; Estes JD; Bosinger SE; Freeman GJ; Ahmed R; Amara RR
JCI Insight; 2018 Sep; 3(18):. PubMed ID: 30232277
[TBL] [Abstract][Full Text] [Related]
8. CTLA-4
McGary CS; Deleage C; Harper J; Micci L; Ribeiro SP; Paganini S; Kuri-Cervantes L; Benne C; Ryan ES; Balderas R; Jean S; Easley K; Marconi V; Silvestri G; Estes JD; Sekaly RP; Paiardini M
Immunity; 2017 Oct; 47(4):776-788.e5. PubMed ID: 29045906
[TBL] [Abstract][Full Text] [Related]
9. PD-1 blockade following ART interruption enhances control of pathogenic SIV in rhesus macaques.
Velu V; Titanji K; Ahmed H; Shetty RD; Chennareddi LS; Freeman GJ; Ahmed R; Amara RR
Proc Natl Acad Sci U S A; 2022 Aug; 119(33):e2202148119. PubMed ID: 35939675
[TBL] [Abstract][Full Text] [Related]
10. Analytical Treatment Interruption after Short-Term Antiretroviral Therapy in a Postnatally Simian-Human Immunodeficiency Virus-Infected Infant Rhesus Macaque Model.
Goswami R; Nelson AN; Tu JJ; Dennis M; Feng L; Kumar A; Mangold J; Mangan RJ; Mattingly C; Curtis AD; Obregon-Perko V; Mavigner M; Pollara J; Shaw GM; Bar KJ; Chahroudi A; De Paris K; Chan C; Van Rompay KKA; Permar SR
mBio; 2019 Sep; 10(5):. PubMed ID: 31488511
[TBL] [Abstract][Full Text] [Related]
11. Increased Proviral DNA in Circulating Cells Correlates with Plasma Viral Rebound in Simian Immunodeficiency Virus-Infected Rhesus Macaques after Antiretroviral Therapy Interruption.
Ziani W; Shao J; Wang X; Russell-Lodrigue K; Liu YZ; Montaner LJ; Veazey RS; Xu H
J Virol; 2021 Feb; 95(6):. PubMed ID: 33408173
[TBL] [Abstract][Full Text] [Related]
12. Myeloid and CD4 T Cells Comprise the Latent Reservoir in Antiretroviral Therapy-Suppressed SIVmac251-Infected Macaques.
Abreu CM; Veenhuis RT; Avalos CR; Graham S; Parrilla DR; Ferreira EA; Queen SE; Shirk EN; Bullock BT; Li M; Metcalf Pate KA; Beck SE; Mangus LM; Mankowski JL; Mac Gabhann F; O'Connor SL; Gama L; Clements JE
mBio; 2019 Aug; 10(4):. PubMed ID: 31431552
[TBL] [Abstract][Full Text] [Related]
13. Initiation of Antiretroviral Therapy Restores CD4+ T Memory Stem Cell Homeostasis in Simian Immunodeficiency Virus-Infected Macaques.
Cartwright EK; Palesch D; Mavigner M; Paiardini M; Chahroudi A; Silvestri G
J Virol; 2016 Aug; 90(15):6699-6708. PubMed ID: 27170752
[TBL] [Abstract][Full Text] [Related]
14. TLR7 agonists induce transient viremia and reduce the viral reservoir in SIV-infected rhesus macaques on antiretroviral therapy.
Lim SY; Osuna CE; Hraber PT; Hesselgesser J; Gerold JM; Barnes TL; Sanisetty S; Seaman MS; Lewis MG; Geleziunas R; Miller MD; Cihlar T; Lee WA; Hill AL; Whitney JB
Sci Transl Med; 2018 May; 10(439):. PubMed ID: 29720451
[TBL] [Abstract][Full Text] [Related]
15. Blocking TLR7- and TLR9-mediated IFN-α production by plasmacytoid dendritic cells does not diminish immune activation in early SIV infection.
Kader M; Smith AP; Guiducci C; Wonderlich ER; Normolle D; Watkins SC; Barrat FJ; Barratt-Boyes SM
PLoS Pathog; 2013; 9(7):e1003530. PubMed ID: 23935491
[TBL] [Abstract][Full Text] [Related]
16. HIV envelope antibodies and TLR7 agonist partially prevent viral rebound in chronically SHIV-infected monkeys.
Moldt B; Chandrashekar A; Borducchi EN; Nkolola JP; Stephenson H; Nagel M; Hung M; Goldsmith J; Pace CS; Carr B; Thomsen ND; Blair WS; Geleziunas R; Barouch DH
PLoS Pathog; 2022 Apr; 18(4):e1010467. PubMed ID: 35452496
[TBL] [Abstract][Full Text] [Related]
17. Antibody and TLR7 agonist delay viral rebound in SHIV-infected monkeys.
Borducchi EN; Liu J; Nkolola JP; Cadena AM; Yu WH; Fischinger S; Broge T; Abbink P; Mercado NB; Chandrashekar A; Jetton D; Peter L; McMahan K; Moseley ET; Bekerman E; Hesselgesser J; Li W; Lewis MG; Alter G; Geleziunas R; Barouch DH
Nature; 2018 Nov; 563(7731):360-364. PubMed ID: 30283138
[TBL] [Abstract][Full Text] [Related]
18. Recombinant Human Interleukin-15 and Anti-PD-L1 Combination Therapy Expands a CXCR3+PD1-/low CD8 T-Cell Subset in Simian Immunodeficiency Virus-Infected Rhesus Macaques.
Chen P; Chen H; Moussa M; Cheng J; Li T; Qin J; Lifson JD; Sneller MC; Krymskaya L; Godin S; Lane HC; Catalfamo M
J Infect Dis; 2020 Feb; 221(4):523-533. PubMed ID: 31562760
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic vaccination of SIV-infected, ART-treated infant rhesus macaques using Ad48/MVA in combination with TLR-7 stimulation.
Bricker KM; Obregon-Perko V; Uddin F; Williams B; Uffman EA; Garrido C; Fouda GG; Geleziunas R; Robb M; Michael N; Barouch DH; Chahroudi A
PLoS Pathog; 2020 Oct; 16(10):e1008954. PubMed ID: 33104758
[TBL] [Abstract][Full Text] [Related]
20. The TLR7 agonist vesatolimod induced a modest delay in viral rebound in HIV controllers after cessation of antiretroviral therapy.
SenGupta D; Brinson C; DeJesus E; Mills A; Shalit P; Guo S; Cai Y; Wallin JJ; Zhang L; Humeniuk R; Begley R; Geleziunas R; Mellors J; Wrin T; Jones N; Milush J; Ferre AL; Shacklett BL; Laird GM; Moldt B; Vendrame E; Brainard DM; Ramgopal M; Deeks SG
Sci Transl Med; 2021 Jun; 13(599):. PubMed ID: 34162752
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
